ALB and head and neck squamous cell carcinoma: Kunyu Yang et al. recently published the results of a phase 2 trial involving patients with resectable stage III-IVB HNSCC who received chemotherapy [albumin-bound paclitaxel (or docetaxel) plus cisplatin] and camrelizumab for three cycles.